IndiaOne Finance - Company Dashboard

Governance Classic Home

Eris Lifesciences LtdPharmaceuticalsINE406M01024Consolidated₹1321.30+10.60 (+0.81%)Jun-26

Valuation

Market Cap₹18.31K Cr

TTM PE28.10x

Forward PE25.94x

PEG7.87

Book Value₹281.62

P/B4.69x

TTM EPS₹47.02

Fwd EPS₹50.93

TTM Revenue₹3.23K Cr

TTM PAT₹665.72 Cr

TTM EBITDA₹1.14K Cr

TTM EBIT₹858.55 Cr

Last Qtr PAT₹143.32 Cr

Last Qtr EBITDA₹296.22 Cr

Last Qtr EBIT₹224.15 Cr

Profitability

ROE17.06%

ROCE13.56%

TTM NPM20.61%

TTM EBITDA %35.29%

Curr OPM16.37%

Last OPM36.78%

Curr NPM—

Last NPM—

Curr EPS₹10.28

Last EPS₹20.60

Balance sheet

Equity₹13.85 Cr

Reserve₹3.89K Cr

Total Debt₹2,358.62 Cr

D/E0.60x

Interest %32.55%

Curr Interest₹46.65 Cr

Price / range

Close₹1321.30

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.81%

1W-2.52%

1M-2.13%

3M-7.64%

6M+0.82%

1Y-19.32%

2Y-5.37%

3Y+61.41%

5Y+72.32%

Diwali-11.88%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	443.99-23.3%	277.31	315.29	650.50	578.64	1,821.74
Other Income	26.38	26.97	25.07	23.59	22.68	98.31
Total Income	470.37-21.8%	304.28	340.36	674.09	601.32	1,920.05
Interest	42.16	42.70	45.20	46.50	45.14	179.54
Expenditure	-406.23+8.7%	-337.05	-321.80	-439.42	-445.06	-1,543.33
PBDT	0	0	0	0	0	0
EBITDA	119.90-44.6%	21.78	77.35	296.88	216.32	612.33
Depreciation	-39.98	-38.82	-38.66	-39.30	-37.60	-154.38
EBIT	79.92-55.3%	-17.04	38.69	257.58	178.72	457.95
PBT	64.14-59.0%	-32.77	3.89	234.67	156.26	362.05
Tax	-15.84	24.17	-0.80	-85.10	-56.27	-118
Equity	13.86	13.85	13.62	0	13.62	13.85
OPM	13.64	-10.77	1.14	36.08	25.99	18.86
Net Profit	48.30-51.7%	-8.60	3.09	149.57	99.99	244.05
NPM	10.27	-2.83	0.91	22.99	16.63	12.71
EPS	3.49-52.5%	-0.63	0.23	10.98	7.34	17.86

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,821.74+7.3%	1,697.75+14.2%	1,486.71+11.7%	1,330.73+9.5%	1,215.73+9.6%	1,108.83
Other Income	98.31	35.51	34.83	17.26	28.99	10
Total Income	1,920.05+10.8%	1,733.26+13.9%	1,521.53+12.9%	1,347.99+8.3%	1,244.72+11.3%	1,118.83
Expenditure	-1,543.33+4.3%	-1,613.21-35.3%	-1,192.70-30.9%	-911.08-15.9%	-786.18-7.7%	-729.94
Interest	-179.54	-220.24	-57.42	-20.81	-2.99	-0.78
PBDT	0	0	0	0	0	0
EBITDA	612.33+25.9%	486.55+7.2%	453.82-10.2%	505.12+4.4%	484+16.0%	417.31
Depreciation	-154.38	-181.77	-102.39	-64.66	-51.46	-37.64
EBIT	457.95+50.3%	304.78-13.3%	351.43-20.2%	440.46+1.8%	432.54+13.9%	379.67
PBT	362.05+201.6%	120.05-63.5%	328.83-24.7%	436.91-4.7%	458.54+17.9%	388.89
Tax	-118	-42.66	-29.12	-38.90	-41.35	-38.29
Equity	13.85	13.62	0	0	0	0
OPM (%)	18.86	6.93	22.00	32.00	37.00	35.00
Net Profit	244.05+215.4%	77.39-74.2%	299.71-24.7%	398.01-4.6%	417.19+19.0%	350.61
NPM (%)	12.71	4.46	20.00	30.00	34.00	31.00
EPS (Rs)	17.86+213.9%	5.69-74.2%	22.04-24.7%	29.27-4.7%	30.70+18.9%	25.82
CEPS	17.83	5.68	22.01	29.23	30.70	25.80

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	873.25+13.0%	756.56	807.45	792.41	773	3,129.42
Other Income	2.39	2.23	0.02	2.81	2.69	7.75
Total Income	875.64+12.9%	758.79	807.47	795.22	775.69	3,137.17
Interest	46.65	45.62	48.82	49.55	48.68	192.67
Expenditure	-695.75-13.0%	-598.18	-645	-622.83	-615.48	-2,481.48
PBDT	0	0	0	0	0	0
EBITDA	296.22+7.1%	273.57	281.61	288.21	276.71	1,120.11
Depreciation	-72.07	-69.57	-70.34	-69.08	-70.51	-279.50
EBIT	224.15+8.7%	204	211.27	219.13	206.20	840.61
PBT	179.89+12.3%	160.61	145.23	172.39	160.21	638.45
Tax	-36.17	119.69	-36.52	-38.20	-36	8.97
Equity	13.86	13.85	0	0	13.62	13.85
OPM	20.54	21.17	17.99	21.68	20.65	20.35
Net Profit	143.32+14.6%	279.10	108.83	134.47	125.10	647.51
NPM	16.37	36.78	13.48	16.91	16.13	20.64
EPS	10.28+18.7%	20.60	7.32	8.82	8.66	45.33

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	3,129.42+8.1%	2,893.64+44.0%	2,009.14+19.2%	1,685.15+25.1%	1,347.04+11.2%	1,211.86
Other Income	7.75	18.36	23.82	11.15	26.09	8.71
Total Income	3,137.17+7.7%	2,912+43.2%	2,032.96+19.8%	1,696.30+23.5%	1,373.14+12.5%	1,220.57
Expenditure	-2,481.48-2.4%	-2,423.19-51.3%	-1,601.72-24.0%	-1,291.66-38.7%	-930.94-12.7%	-826.07
Interest	-192.67	-231.29	-84.80	-26.17	-4.15	-1.80
PBDT	0	0	0	0	0	0
EBITDA	1,120.11+10.1%	1,017.20+50.7%	674.83+25.7%	536.75+10.7%	484.96+12.6%	430.58
Depreciation	-279.50	-315.46	-182.61	-117.09	-64.71	-42.99
EBIT	840.61+19.8%	701.74+42.6%	492.22+17.3%	419.66-0.1%	420.25+8.4%	387.59
PBT	638.45+30.6%	488.81+13.3%	431.24+6.6%	404.64-8.5%	442.20+12.1%	394.50
Tax	8.97	-114.20	-34.19	-30.48	-36.41	-39.36
Equity	13.85	13.62	0	0	0	0
OPM (%)	20.35	16.79	21.21	23.85	32.20	32.32
Net Profit	647.51+72.8%	374.67-5.6%	397.05+6.1%	374.16-7.8%	405.79+14.3%	355.14
NPM (%)	20.64	12.87	19.53	22.06	29.55	29.10
EPS (Rs)	45.33+75.4%	25.85-10.3%	28.82+2.6%	28.10-6.0%	29.89+14.3%	26.16
CEPS	45.26	25.81	28.79	28.07	29.88	26.14

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2027	Interim Dividend	7.21	29 May 2026
2025	Interim Dividend	7.35	13 Feb 2025
2023	Interim Dividend	7.35	11 Aug 2022
2022	Interim Dividend	6.01	05 Aug 2021
2021	Interim Dividend	5.5	13 Aug 2020
2020	Interim Dividend	2.87	19 Mar 2020

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split